Multilevel models for meta-analysis, and their application to absolute risk differences
- PMID: 11763548
- DOI: 10.1177/096228020101000602
Multilevel models for meta-analysis, and their application to absolute risk differences
Abstract
Meta-analysis can be considered a multilevel statistical problem, since information within studies is combined in the presence of potential heterogeneity between studies. Here a general multilevel model framework is developed for meta-analysis to combine either summary data or individual patient outcome data from each study, and to include either study or individual level covariates that might explain heterogeneity. Classical and Bayesian approaches to estimation are contrasted. These methods are applied to a meta-analysis of trials of thrombolytic therapy after myocardial infarction. Subgroups within the trials were available, categorized by the time delay until treatment, so that a three-level random effects model that includes time delay as a covariate is proposed. In addition it was desired to represent the treatment effect as an absolute risk reduction, rather than the conventional odds ratio. We show how this can be achieved within a Bayesian analysis, while still recognizing the binary nature of the original outcome data.
Similar articles
-
Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales.Stat Med. 2002 Jun 15;21(11):1601-23. doi: 10.1002/sim.1189. Stat Med. 2002. PMID: 12111922
-
Meta-analysis of continuous outcome data from individual patients.Stat Med. 2001 Aug 15;20(15):2219-41. doi: 10.1002/sim.918. Stat Med. 2001. PMID: 11468761
-
Bayesian meta-analysis: The role of the between-sample heterogeneity.Stat Methods Med Res. 2018 Dec;27(12):3643-3657. doi: 10.1177/0962280217709837. Epub 2017 May 16. Stat Methods Med Res. 2018. PMID: 28511616
-
A Bayesian sensitivity study of risk difference in the meta-analysis of binary outcomes from sparse data.Expert Rev Pharmacoecon Outcomes Res. 2015 Apr;15(2):317-22. doi: 10.1586/14737167.2015.1011131. Epub 2015 Feb 11. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 25673174 Review.
-
Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.Ann Emerg Med. 2008 Dec;52(6):665-76. doi: 10.1016/j.annemergmed.2008.08.033. Ann Emerg Med. 2008. PMID: 19027496 Review.
Cited by
-
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.PLoS Med. 2012;9(8):e1001300. doi: 10.1371/journal.pmed.1001300. Epub 2012 Aug 28. PLoS Med. 2012. PMID: 22952439 Free PMC article.
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.PLoS Med. 2009 Jul 21;6(7):e1000100. doi: 10.1371/journal.pmed.1000100. Epub 2009 Jul 21. PLoS Med. 2009. PMID: 19621070 Free PMC article.
-
The Effect of Preoperative Administration of Glucocorticoids on the Postoperative Complication Rate in Liver Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.J Clin Med. 2024 Apr 3;13(7):2097. doi: 10.3390/jcm13072097. J Clin Med. 2024. PMID: 38610862 Free PMC article. Review.
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.BMJ. 2009 Jul 21;339:b2700. doi: 10.1136/bmj.b2700. BMJ. 2009. PMID: 19622552 Free PMC article.
-
Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials.BMC Cancer. 2024 Nov 28;24(1):1467. doi: 10.1186/s12885-024-13160-2. BMC Cancer. 2024. PMID: 39609770 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical